XKRX353810
Market cap98mUSD
Dec 26, Last price
4,385.00KRW
1D
-4.04%
1Q
10.47%
IPO
223.62%
Name
Easy Bio Inc
Chart & Performance
P/E
9.44
P/S
0.89
EPS
464.73
Div Yield, %
1.79%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
165.39b
+6.32%
Net income
15.54b
+70.24%
CFO
33.68b
P
Dividend
Dec 27, 202375 KRW/sh
Profile
EASY BIO,Inc. provides specialized piglet feed and feed additives solutions in South Korea and internationally. The company was founded in 2020 and is based in Seoul, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||
Revenues | 165,385,091 6.32% | 155,557,100 20.16% | 129,457,805 46.91% | |
Cost of revenue | 132,449,054 | 126,240,719 | 103,293,577 | |
Unusual Expense (Income) | ||||
NOPBT | 32,936,037 | 29,316,382 | 26,164,228 | |
NOPBT Margin | 19.91% | 18.85% | 20.21% | |
Operating Taxes | 3,964,560 | 2,636,738 | 3,211,986 | |
Tax Rate | 12.04% | 8.99% | 12.28% | |
NOPAT | 28,971,477 | 26,679,644 | 22,952,241 | |
Net income | 15,543,779 70.24% | 9,130,741 -16.02% | 10,872,799 4.29% | |
Dividends | (2,625,983) | (2,560,284) | (2,560,284) | |
Dividend yield | 2.12% | 1.86% | 1.58% | |
Proceeds from repurchase of equity | ||||
BB yield | ||||
| Debt | ||||
Debt current | 51,824,327 | 65,040,124 | 46,327,777 | |
Long-term debt | 31,453,099 | 18,346,287 | 5,961,147 | |
Deferred revenue | 3 | 1,793,388 | 2,597,055 | |
Other long-term liabilities | 2,858,052 | (60) | 80 | |
Net debt | 44,375,247 | 33,849,275 | 21,485,224 | |
| Cash flow | ||||
Cash from operating activities | 33,684,377 | (8,124,101) | 14,065,939 | |
CAPEX | (1,886,065) | (2,049,092) | (1,838,999) | |
Cash from investing activities | (41,340,009) | 513,768 | (20,060,331) | |
Cash from financing activities | (3,408,068) | 27,877,985 | 6,229,312 | |
FCF | 3,385,341 | 8,347,293 | 12,483,734 | |
| Balance | ||||
Cash | 30,712,115 | 41,383,191 | 21,896,608 | |
Long term investments | 8,190,063 | 8,153,945 | 8,907,093 | |
Excess cash | 30,632,924 | 41,759,281 | 24,330,810 | |
Stockholders' equity | 45,385,010 | 57,181,209 | 50,237,253 | |
Invested Capital | 120,675,905 | 93,524,596 | 73,140,415 | |
ROIC | 27.05% | 32.02% | 36.11% | |
ROCE | 21.68% | 21.52% | 26.52% | |
| EV | ||||
Common stock shares outstanding | 34,137 | 34,137 | 34,137 | |
Price | 3,620.00 -10.06% | 4,025.00 -14.99% | 4,735.00 | |
Market cap | 123,576,374 -10.06% | 137,401,908 -14.99% | 161,639,263 | |
EV | 171,342,500 | 174,099,022 | 185,620,685 | |
EBITDA | 36,627,960 | 33,079,386 | 28,964,958 | |
EV/EBITDA | 4.68 | 5.26 | 6.41 | |
Interest | 3,219,267 | 1,720,296 | 1,104,963 | |
Interest/NOPBT | 9.77% | 5.87% | 4.22% | |